Categories
-
Adhesives
5
Amines
93
Amino Acids
181
Analytical Reagents
673
Antibiotics
252
Bioactive Small Molecules
718
Aroma Chemicals
206
Biochemicals
1014
Boronic Acids
4
Buffers
99
Building Blocks
1782
Carbohydrates
176
Catalysts
99
Chiral Compounds
54
Coccus nucifera oil
0
Detergents
59
Diagnostic Raw Materials
251
Flavours and Fragrance Materials
204
Fluorinated Products
42
Furans
5
Gases in Solution
50
Grignard Reagents
19
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
324
Ion-Pair Reagents
24
Ligands
80
Organics
1307
Oxazoles
3
Peptide Reagents
90
Phenols
44
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
44
Reagents
97
Research Organics & Inorganics
753
Salts
284
Sealing Compounds
1
Sherclin
2
Solvents
124
Stains & Indicators
289
Sugars
63
Tailor-made solutions
3
Testing Standards
4
Uncategorised
172
Water Analysis
10
D-Cycloserine
(90028981 | 68-41-7)
| CAS: | 68-41-7 |
|---|---|
| Molecular Formula: | C3H6N2O2 |
| Molecular Weight: | 102.09 |
| Availablility: | Inquire for Status |
|---|---|
| Downloads: | | |
| 90028981-1g | 1g | £19.50 | |
| Bulk Order | |||
| 90028981-1g | 1g | €27.30 | |
| Bulk Order | |||
| 90028981-1g | 1g | $29.30 | |
| Bulk Order | |||
Safety Data Sheet
Certificate of Analysis
Product Detail
| Product Code | 90028981 | ||||
| Product Name | D-Cycloserine | ||||
| Categories | Antibiotics Bioactive Small Molecules Chiral Compounds Organics Research Organics & Inorganics | ||||
| CAS | 68-41-7 | ||||
| Molecular Formula | C3H6N2O2 | ||||
| Molecular Weight | 102.09 | ||||
| Storage Details | -15 to -20 °C | ||||
| Harmonised Tariff Code | 2934999090 |
Product Specification
| Specific rotation | +108°~ +114° | ||||
| pH | 5.5~6.5 | ||||
| Loss on Drying | Not more than 1.0% | ||||
| Assay | Not less than 90% | ||||
| Crystallinity | Should comply | ||||
| Appearance | White to pale yellowish crystalline powder |
Safety Information
| Pictograms |
|
||||
| Signal word | none | ||||
| Hazard statements |
|
||||
| Precautionary statements |
|